AIC
CORT icon

Ameritas Investment Company’s Corcept Therapeutics CORT Stock Holding History

Ameritas Investment Company’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-609
Closed -$14.5K – 986
2021
Q1 		$14.5K Buy
+609
New +$16.3K ﹤0.01% 1400

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameritas Investment Company's CORT Position: Q2 2021 in Review

Ameritas Investment Company sold out of Corcept Therapeutics (CORT) in Q2 2021, closing a stake of 609 shares — an estimated $14.5K sold.

Ameritas Investment Company first reported a position in CORT in Q1 2021 and held it in 1 quarter. The position peaked at $14.5K in Q1 2021. 199 funds tracked by Wall St. Rank hold CORT as of Q2 2021.

  • Ameritas Investment Company reported no remaining Corcept Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 609 Corcept Therapeutics shares in Q2 2021, an estimated $14.5K.
  • Ameritas Investment Company first reported a position in Corcept Therapeutics in Q1 2021 and held it in 1 quarter.
  • Ameritas Investment Company's Corcept Therapeutics position peaked at $14.5K in Q1 2021.
  • 199 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.